SE8700776L - Forfarande for framstellning av enkainid - Google Patents

Forfarande for framstellning av enkainid

Info

Publication number
SE8700776L
SE8700776L SE8700776A SE8700776A SE8700776L SE 8700776 L SE8700776 L SE 8700776L SE 8700776 A SE8700776 A SE 8700776A SE 8700776 A SE8700776 A SE 8700776A SE 8700776 L SE8700776 L SE 8700776L
Authority
SE
Sweden
Prior art keywords
enkainid
procedure
producing
encainide
benzanilide
Prior art date
Application number
SE8700776A
Other languages
English (en)
Other versions
SE464301B (sv
SE8700776D0 (sv
Inventor
J L Dillon
R H Spector
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8700776D0 publication Critical patent/SE8700776D0/sv
Publication of SE8700776L publication Critical patent/SE8700776L/sv
Publication of SE464301B publication Critical patent/SE464301B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE8700776A 1986-02-25 1987-02-24 Foerfarande foer framstaellning av enkainid SE464301B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/833,295 US4675409A (en) 1986-02-25 1986-02-25 Process for the preparation of encainide

Publications (3)

Publication Number Publication Date
SE8700776D0 SE8700776D0 (sv) 1987-02-24
SE8700776L true SE8700776L (sv) 1987-08-26
SE464301B SE464301B (sv) 1991-04-08

Family

ID=25264016

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8700776A SE464301B (sv) 1986-02-25 1987-02-24 Foerfarande foer framstaellning av enkainid

Country Status (23)

Country Link
US (1) US4675409A (sv)
JP (1) JPS62240659A (sv)
KR (1) KR900001203B1 (sv)
AT (1) AT394716B (sv)
AU (1) AU597939B2 (sv)
BE (1) BE1000112A5 (sv)
CA (1) CA1291483C (sv)
CH (1) CH671223A5 (sv)
DE (1) DE3705664A1 (sv)
DK (1) DK94487A (sv)
ES (2) ES2002637A6 (sv)
FI (1) FI85853C (sv)
FR (1) FR2595353B1 (sv)
GB (1) GB2187189B (sv)
GR (1) GR870281B (sv)
HU (1) HU196960B (sv)
IL (1) IL81657A0 (sv)
IT (1) IT1203501B (sv)
LU (1) LU86785A1 (sv)
NL (1) NL8700452A (sv)
PT (1) PT84348B (sv)
SE (1) SE464301B (sv)
ZA (1) ZA871334B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800226A (en) * 1986-02-25 1989-01-24 Bristol-Myers Company Process intermediate for the preparation of encainide
CA2629836A1 (en) * 2005-11-17 2007-10-04 Novartis Ag Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US4000143A (en) * 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
CA961038A (en) * 1971-03-03 1975-01-14 Joseph L. Minielli Substituted piperidines
US4064254A (en) * 1971-03-03 1977-12-20 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
US4394507A (en) * 1981-12-14 1983-07-19 Mead Johnson & Company Process for production of encainide

Also Published As

Publication number Publication date
DK94487A (da) 1987-08-26
GB8703882D0 (en) 1987-03-25
AU597939B2 (en) 1990-06-14
NL8700452A (nl) 1987-09-16
FR2595353B1 (fr) 1990-11-30
FI85853C (sv) 1992-06-10
FI85853B (fi) 1992-02-28
CA1291483C (en) 1991-10-29
ATA41287A (de) 1991-11-15
SE464301B (sv) 1991-04-08
JPS62240659A (ja) 1987-10-21
DK94487D0 (da) 1987-02-24
KR900001203B1 (ko) 1990-02-28
IT8719475A0 (it) 1987-02-24
DE3705664C2 (sv) 1989-09-28
IL81657A0 (en) 1987-09-16
SE8700776D0 (sv) 1987-02-24
HUT43563A (en) 1987-11-30
AT394716B (de) 1992-06-10
US4675409A (en) 1987-06-23
IT1203501B (it) 1989-02-15
AU6924687A (en) 1987-08-27
LU86785A1 (fr) 1987-09-15
CH671223A5 (sv) 1989-08-15
FI870767A0 (fi) 1987-02-23
BE1000112A5 (fr) 1988-03-29
FI870767A (fi) 1987-08-26
GR870281B (en) 1987-06-30
FR2595353A1 (fr) 1987-09-11
PT84348B (pt) 1989-09-14
KR870007887A (ko) 1987-09-22
PT84348A (en) 1987-03-01
HU196960B (en) 1989-02-28
ZA871334B (en) 1987-10-28
DE3705664A1 (de) 1987-08-27
GB2187189B (en) 1990-01-10
ES2007062A6 (es) 1989-06-01
GB2187189A (en) 1987-09-03
ES2002637A6 (es) 1988-09-01

Similar Documents

Publication Publication Date Title
PH17914A (en) Process for the production of new optically active 1,4-dihydropyridine compounds
NO871640L (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
IT7927064A0 (it) Composizione di mucopolisaccaride avente un'azione regolatrice della coagulazione, medicamento contenente tale composizione eprocedimento per prepararla.
IL56944A (en) Process for the preparation of cis-hexahydrodibenzopyranones and 3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives
ATE104265T1 (de) Herstellung von 1,1,1-2-tetrafluorethan.
DE3063336D1 (en) Process for the production of optically active threo-3-(3,4-dihydroxyphenyl) serine, and product thus produced
DE3760473D1 (en) Process for the manufacture of 2,2-dimethylpropan-1,3-diol
EP0237735A3 (en) 3,7-disubstituted-3-cephem compounds and process for production of the same
DE3069496D1 (de) 2,3-dialkoxy-1,4-quinone derivatives; method of producing 1,4-quinone derivatives
PL266932A1 (en) The method of manufacture of new 1,4-benzodiasepine
IT1123137B (it) "3",4"-diaciltilosina e procedimento per la sua produzione
SE8700776L (sv) Forfarande for framstellning av enkainid
EP0270965A3 (en) Process for the preparation of substituted 3,5-dichloro-2,4-difluorobenzenes
ES2061481T3 (es) Derivados de 3,4-dihidrobenzoazina opticamente activos y procedimiento para la preparacion de los mismos.
SU1178325A3 (ru) "cпocoб пoлучehия пpoизboдhыx 2,2-диaлkил-18,19-диhopпpeгh-4-eh-3,20-диoha"
DE3062872D1 (en) Process for the production of glazing-pigment forms of 4,4',7,7'-tetrachlorothio indigo
SE8504409D0 (sv) Novel chemical intermediates
IL74593A0 (en) Propargyl esters,their preparation and their use as pesticides
IL49548A0 (en) A method of producing 1,4-benzodiazepines and certain such novel compounds
PT85023A (en) Process for the preparation of substituted 2-phenylacetil-1,3,5-cyclohexanetriones and of intermediates
SE8207112D0 (sv) Forbettrat forfarande for framstellning av enkainid
DK325287D0 (da) 4-benzyloxy-3-pyrrolin-2-on, fremgangsmaade til fremstilling deraf samt anvendelse deraf til fremstilling af tetramsyre
SU697513A1 (ru) Способ получени 5-арилиденамино -6-арил-2-тригалогенметил-2,3-дегидро1,3,5-оксадиазин-4-онов
GB2014147B (en) Production of 1,3-diaza-heterocycles
NO871761D0 (no) Fremgangsmaate for fremstilling av varmeisolerende tekstilprodukt.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8700776-1

Effective date: 19940910

Format of ref document f/p: F